Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.

Poland

All drugs from this manufacturer

  • EVEROLIMUS VIPHARM

    This is an anticancer medicine used in adults for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

    Dosage form: tablets

    Active substance Dosage
    everolimus 2.5 mg

    ATC: L01EG02

  • EVEROLIMUS VIPHARM

    The medicinal product is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

    Dosage form: tablets

    Active substance Dosage
    everolimus 5 mg

    ATC: L01EG02

  • EVEROLIMUS VIPHARM

    The medicine is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

    Dosage form: tablets

    Active substance Dosage
    everolimus 10 mg

    ATC: L01EG02